Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Mathijssen, Ron H J"'
Autor:
Bleckman RF; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. r.f.bleckman@umcg.nl.; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. r.f.bleckman@umcg.nl., Broekman KE; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Roets E; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mohammadi M; Leiden University Medical Center, Leiden, The Netherlands., Desar IME; Radboud University Medical Center, Nijmegen, The Netherlands., Gelderblom H; Leiden University Medical Center, Leiden, The Netherlands., Mathijssen RHJ; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Steeghs N; The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Graeff P; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Reyners AKL; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Publikováno v:
Drugs & aging [Drugs Aging] 2024 Feb; Vol. 41 (2), pp. 165-176. Date of Electronic Publication: 2023 Dec 20.
Autor:
Bleckman RF; University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Electronic address: r.f.bleckman@umcg.nl., Roets E; The Netherlands Cancer Institute Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., IJzerman NS; The Netherlands Cancer Institute Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Mohammadi M; Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Bonenkamp HJJ; Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands., Gelderblom H; Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Mathijssen RHJ; Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Steeghs N; University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Reyners AKL; University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., van Etten B; University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jun; Vol. 186, pp. 113-121. Date of Electronic Publication: 2023 Mar 16.
Autor:
van Elst JM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, the Netherlands., IJzerman NS; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, the Netherlands., de Haan JJ; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, the Netherlands. j.j.de.haan@umcg.nl.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Mar; Vol. 30 (3), pp. 2307-2315. Date of Electronic Publication: 2021 Nov 02.
Autor:
van Houdt WJ; Sarcoma Unit, Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., IJzerman NS; Sarcoma Unit, Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Marjolein Schrijver A; Sarcoma Unit, Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Huis In 't Veld E; Sarcoma Unit, Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Thway K; Sarcoma Unit, Department of Pathology, Royal Marsden Hospital, London, UK., Jones RL; Sarcoma Unit, Department of Medical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Fotiadis N; Sarcoma Unit, Department of Radiology, Royal Marsden Hospital, London, UK., Hayes AJ; Sarcoma Unit, Department of Surgical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Bruining A; Sarcoma Unit, Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Zavrakidis I; Netherlands Cancer Institute - Antoni van Leeuwenhoek, Department of Epidemiology and Biostatistics, Amsterdam, the Netherlands., van Coevorden F; Sarcoma Unit, Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Steeghs N; Sarcoma Unit, Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Strauss DC; Sarcoma Unit, Department of Surgical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Smith MJF; Sarcoma Unit, Department of Surgical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK.
Publikováno v:
Annals of surgery [Ann Surg] 2021 Dec 01; Vol. 274 (6), pp. e1093-e1098.
Autor:
Verboom MC; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. m.c.verboom@lumc.nl., Kloth JSL; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Steeghs N; Department of Medical Oncology and Clinical Pharmacology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
The pharmacogenomics journal [Pharmacogenomics J] 2019 Oct; Vol. 19 (5), pp. 473-479. Date of Electronic Publication: 2019 Feb 04.
Autor:
Verboom MC; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: m.c.verboom@lumc.nl., Kloth JSL; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., van der Straaten T; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Reyners AKL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Steeghs N; Department of Medical Oncology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 Nov; Vol. 86, pp. 226-232. Date of Electronic Publication: 2017 Oct 18.
Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure.
Autor:
Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3008 AE, Rotterdam, The Netherlands., Eechoute K; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3008 AE, Rotterdam, The Netherlands., Kloth JS; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3008 AE, Rotterdam, The Netherlands., de Man FM; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3008 AE, Rotterdam, The Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3008 AE, Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3008 AE, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3008 AE, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3008 AE, Rotterdam, The Netherlands. a.mathijssen@erasmusmc.nl.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2017 Mar; Vol. 56 (3), pp. 305-310.
Autor:
Schiavon G; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; The Royal Marsden NHS Foundation Trust, Breast Unit, London, United Kingdom. Electronic address: gaia.schiavon@icr.ac.uk., Ruggiero A; Dept. of Radiology, Erasmus University Medical Center, Rotterdam, The Netherlands; Dept. of Radiology, Addenbrooke's Hospital, Cambridge, United Kingdom., Bekers DJ; TNO Technical Sciences, The Hague, The Netherlands., Barry PA; The Royal Marsden NHS Foundation Trust, Breast Unit, London, United Kingdom., Sleijfer S; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kloth J; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Krestin GP; Dept. of Radiology, Erasmus University Medical Center, Rotterdam, The Netherlands., Schöffski P; Dept. of General Medical Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Verweij J; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mathijssen RH; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2014 Mar; Vol. 50 (5), pp. 972-80. Date of Electronic Publication: 2014 Jan 27.
Autor:
Oudijk L; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Josephine Nefkens Institute, Rotterdam, The Netherlands. l.oudijk@erasmusmc.nl, Gaal J, Korpershoek E, van Nederveen FH, Kelly L, Schiavon G, Verweij J, Mathijssen RH, den Bakker MA, Oldenburg RA, van Loon RL, O'Sullivan MJ, de Krijger RR, Dinjens WN
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2013 Mar; Vol. 26 (3), pp. 456-63. Date of Electronic Publication: 2012 Nov 23.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Feb 15; Vol. 19 (4), pp. 950. Date of Electronic Publication: 2013 Feb 05.